THE ODDS

Our Response TO
COVID-19

OUR LATEST
ACQUISITION

Differentiated Approach

We are continuously evaluating innovative ways to overcome deadly and difficult-to-treat diseases.

Accelerating Innovation

Learn more about Chimerix’s approach to investing in novel drug candidates that meaningfully improve the probability of survival and the collaborative team driving the development of these promising new therapies.

Our COmmitment

Chimerix is focused on identifying and developing new oncology and biodefense therapies to rewrite the odds for patients.